1,2,3,4-tetrahydroisoquinoline and Cancer of Liver

1,2,3,4-tetrahydroisoquinoline has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, YS; Jin, F; Mach, RH; Sun, YT; Wang, GF; Wang, Y; Xie, XY; Yang, YQ	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Cancer of Liver

Article	Year
Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands. European journal of medicinal chemistry, 2018, Mar-10, Volume: 147 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Guinea Pigs; Humans; Ligands; Liver Neoplasms; Molecular Structure; Rats; Receptors, sigma; Structure-Activity Relationship; Tetrahydroisoquinolines	2018

Article

Year

Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.

European journal of medicinal chemistry, 2018, Mar-10, Volume: 147

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Guinea Pigs; Humans; Ligands; Liver Neoplasms; Molecular Structure; Rats; Receptors, sigma; Structure-Activity Relationship; Tetrahydroisoquinolines

2018